Begin typing your search above and press return to search.
proflie-avatar
Login
exit_to_app
DEEP READ
Ukraine
access_time 16 Aug 2023 11:16 AM IST
The Russian plan: Invade Japan and South Korea
access_time 16 Jan 2025 3:32 PM IST
Putin
access_time 2 Jan 2025 1:36 PM IST
What is Christmas?
access_time 26 Dec 2024 11:19 AM IST
Munambam Waqf issue decoded
access_time 16 Nov 2024 10:48 PM IST
exit_to_app
Homechevron_rightLifestylechevron_rightHealthchevron_rightIndia to launch first...

India to launch first Covid nasal vaccine on January 26

text_fields
bookmark_border
covid vaccine
cancel

New Delhi: Bharat Biotech is all set to launch its intranasal COVID-19 vaccine iNCOVACC on January 26. This is the first of its kind in the country, said the company's chairman and managing director Krishna Ella.

"Our nasal vaccine will be officially launched on January 26, on Republic Day." He was speaking at the India International Science Festival in Bhopal during the 'New Frontiers in Science' segment organised at the Maulana Azad National Institute of Technology (MANIT).

The homegrown company announced in December that it will sell the intranasal vaccine for Rs 325 per shot for procurement by the government and Rs 800 per shot for private vaccination centres.

The vaccine will be used as a heterologous booster. It will be first available in private hospitals. It received approval from the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18.

An intranasal vaccine stimulates a broad immune response - neutralising IgG, mucosal IgA, and T cell responses. The immune response at the nasal mucosa which is the site of infection is crucial to blocking infection and transmission of Covid-19.

Show Full Article
TAGS:covid vaccineBharat BiotechCovid nasal vaccine
Next Story